Skip to main content

ESTUDIO DE LA REGULACIÓN DEL GEN LPIN1 EN PACIENTES CON OBESIDAD Y DIABETES MELLITUS TIPO 2. ANÁLISIS IN VITRO EN ADIPOCITOS HUMANOS DE SU RESPUESTA A DIFERENTES ESTÍMULOS LIPOLÍTICOS.

JCI-2009-04086

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Contratación e Incorporación de RRHH
Subprogram Subprograma Juan de la Cierva (JDC)
Call Juan de la Cierva Incorporación
Call year 2009
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Formación e Incorporación de Investigadores
Beneficiary centre FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE VIRGILI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes

  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Garrido Sánchez, Lourdes|||0000-0003-0756-9606
  • Gomez-Carrillo, Víctor
  • Gallego-Perales, José Luis
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Calleja, Fernando
  • Gomez-Huelgas, Ricardo
  • Badimon, Lina|||0000-0002-9162-2459
  • Tinahones, Francisco J.|||0000-0001-6871-4403
OBJECTIVE-Oxidized lipoproteins and antioxidized LDL antibodies (antioxLDLabs) have been detected in human plasma and atherosclerotic lesions. The principle aimof this study was to analyze the possible relationship between IgG and IgM antioxLDLabs and factors involved in different metabolic pathways (inflammation, lipid metabolism, apoptosis, and cell cycle arrest profile) in the occluded popliteal artery (OPA) compared with the femoral vein (FV). RESEARCH DESIGN AND METHODS-Fifteen patients with advanced atherosclerosis and type 2 diabetes undergoing lower limb amputation participated in this study. Each patient had OPA and FV biopsy specimens and peripheral arterial occlusive disease. By real-time PCR, gene expression was analyzed from the OPA and FV specimens, and antioxLDLab levels were measured by specific enzyme-linked immunosorbent assay. RESULTS-The OPA and FV showed a positive correlation between only IgM antioxLDLab levels and the expression of genes involved in different metabolic pathways, including inflammation (TFPI), apoptosis (BAX, caspase 3, AKT1), plaque disruption (MMP2 and MMP10), lipid metabolism (SCARB1, PPARg), and cell turnover (CDKN1A), and genes for transcription and growth factors (NFkB and VEGFA, respectively). CONCLUSIONS-The results show that gene expression in the metabolic pathways (apoptosis, lipid metabolism, and inflammation) in theOPA and FV are directly related to the levels of IgM antioxLDLabs. © 2013 by the American Diabetes Association.